23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal to take the ... according to a filing with the U.S. Securities and Exchange Commission. The stock plunged 33% on Monday to close at $1.47, down more ...

The latest plan by 23andMe co-founder and CEO Anne Wojcicki to acquire the genetic testing company was rejected by a special committee of the Sunnyvale company's board, the group said Monday.

The special committee of the board of directors of 23andMe (ME) confirmed receipt of a non-binding proposal from Anne Wojcicki, CEO,

Experts say the CEO’s second attempt to buy back the troubled DNA startup comes with a slew of corporate governance red flags.

23andMe's special committee of independent directors on Monday rejected CEO Anne Wojcicki's proposal ... to a filing with the U.S. Securities and Exchange Commission. The stock plunged 33% on ...

The Special Committee has reviewed Ms. Wojcicki’s acquisition proposal in consultation with its financial and legal advisors, and has unanimously determined to reject the proposal. Moelis & Company LLC is serving as financial advisor and Goodwin Procter LLP is serving as legal advisor to the Special Committee.